What Dosch Pharmaceuticals does

Dosch Pharmaceuticals Pvt. Ltd. is a Mumbai-based, privately held B2B pharmaceutical services company that operates as an integrated enablement platform for pharmaceutical manufacturers in Central Africa. Established approximately three decades ago, the company qualifies and sources APIs, excipients, packaging materials, and finished goods from India, China, and Europe to WHO Prequalification standards, then delivers them via air and sea freight into the Central African corridor at a rate of more than 1,000 container shipments annually, completing the route with door-to-plant final-mile logistics.

The company's offering is structured around six interconnected service pillars: DP·01 Global Sourcing & Procurement; DP·02 Machinery, Engineering & Technical Support (covering production line sourcing, inspection, and commissioning for Oral Solid Dosage and Small Volume Parenterals); DP·03 Project Management & Facility Development (including segregated GMP containment blocks); DP·04 Formulation & Product Development (with BA/BE study coordination through CROs in approved jurisdictions); DP·05 Technical Manpower & Capability Building (recruitment and deployment of audit-experienced professionals, plus training of local teams); and DP·06 Logistics into Central Africa. Together these form a closed loop in which market intelligence from the region feeds formulation development, which drives procurement, which feeds engineered facilities operated by Dosch-deployed technical teams, with logistics closing the physical distance. Dose-wise, the company supports over 500 SKUs across antimalarials, anti-tuberculars, antiretrovirals, anti-infectives, and broader essential medicines.

The business operates an enterprise field-sales motion targeting pharmaceutical manufacturers in Central Africa and global health procurement programs, with quote-based project engagements spanning procurement markups (transaction-fee revenue on multi-origin sourcing), project-based engineering and facility development fees, professional services for technical manpower deployment, and transaction-fee logistics revenue. Dosch is recognized by the Government of India as a Three Star Export House and holds all required pharmaceutical export and import-export licenses. It is a private limited company with no disclosed parent, no disclosed institutional investors, and no management team information available in the public source material.

Name

Dosch Pharmaceuticals

Legal name

Dosch Pharmaceuticals Pvt. Ltd.

Website

https://dosch.com

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

11–50 employees

Short description

Mumbai-based B2B pharmaceutical services platform that enables pharmaceutical manufacturing in Central Africa through integrated multi-origin sourcing from India, China, and Europe, WHO Prequalification-standard vendor qualification, engineering and facility development, technical manpower deployment, and door-to-plant logistics at over 1,000 container shipments annually.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)

akta.pro secondary industries

CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Pharmaceutical procurement
• Pharmaceutical manufacturing enablement
• WHO prequalification sourcing
• GMP facility development
• Pharma logistics services

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Procurement and Sourcing Services: Multi-origin procurement of APIs, excipients, packaging materials, and finished goods across India, China, and Europe, qualified to WHO PQ standards. Revenue likely generated through markup on procurement and logistics services.
2. Engineering and Technical Services: Machinery sourcing, facility development, production line commissioning, and ongoing technical support. Typically project-based engagements for GMP facility development and equipment procurement.
3. Technical Manpower Deployment: Recruitment, deployment, and management of pharmaceutical professionals including plant managers, QA/QC specialists, and regulatory affairs personnel.
4. Logistics Services: Air and sea freight coordination, customs documentation, regulatory compliance, and door-to-plant delivery services into Central Africa.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Dosch Pharmaceuticals operates as an integrated pharmaceutical manufacturing enablement platform, serving as the global procurement, engineering, and technical arm of pharmaceutical manufacturers in Central Africa. The company sources APIs, excipients, packaging, and finished goods from India, China, and Europe qualified to WHO Prequalification standards, commissions Oral Solid Dosage and Small Volume Parenteral production lines, develops formulations for regional conditions, deploys pharmaceutical professionals with USFDA/EU/WHO audit experience, and delivers door-to-plant logistics across the Central Africa corridor.

Product overview

Dosch Pharmaceuticals operates as an integrated pharmaceutical manufacturing enablement platform offering six interconnected service capabilities. The core offering includes Global Sourcing & Procurement (DP·01) for APIs, excipients and finished goods; Machinery, Engineering & Technical Support (DP·02) for production line commissioning; Project Management & Facility Development (DP·03) for GMP facilities; Formulation & Product Development (DP·04) for regional market adaptation; Technical Manpower & Capability Building (DP·05) for skilled personnel deployment; and Logistics into Central Africa (DP·06) for door-to-plant delivery. These six disciplines form a closed loop where development drives sourcing, sourcing feeds engineered facilities, their people operate them, and logistics closes the distance.

Differentiator

Problem solved

Functional benefit

Products and services

• DP·01 - Global Sourcing & Procurement

Quantifiable outcome

• 30+ years of uninterrupted operation in Central Africa corridor
• +3 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Zuellig Pharma: Asia's largest pharmaceutical distribution services group operating across 13+ Asian markets. A broad incumbent with overlapping pharma distribution and regulatory documentation capabilities, though focused on Asia rather than Africa.
• Cencora (AmerisourceBergen): Global pharmaceutical distribution and solutions company serving manufacturers, pharmacies, and healthcare providers worldwide. Comparable in pharmaceutical sourcing, distribution, and consulting services to manufacturers, at much larger scale.
• Viatris: Global generics and specialty pharmaceutical company with significant presence in global health, supplying ARVs and essential medicines to low-income countries. Comparable in global health product portfolio but operates as a manufacturer rather than intermediary.
• McKesson: One of the world's largest pharmaceutical wholesalers and distributors, with global supply chain infrastructure and pharmaceutical sourcing capabilities. Comparable as a broad pharma distribution incumbent, though primarily serving North America and Europe.

Direct peers

• Imperial Health Sciences: South African pharmaceutical distribution and supply chain company serving sub-Saharan African markets with warehousing, distribution, and supply chain services. Comparable regional pharma logistics capabilities for the African continent.
• IDA Foundation: Dutch non-profit pharmaceutical supplier supplying essential medicines to low- and middle-income countries via WHO PQ-qualified sourcing. Shares the global health procurement and WHO PQ documentation discipline that defines Dosch's regulatory moat.
• Missionpharma: Danish pharmaceutical supplier specializing in global health procurement and distribution to developing countries, with WHO PQ-aligned product portfolios. Closest analogue to Dosch's procurement-plus-logistics model into Africa.

Others

• Axios International: Healthcare access consultancy and supply chain solutions provider focused on improving access to medicines in emerging markets. Thematically adjacent — comparable in global health access mission and emerging-market pharma expertise, but consultancy-led rather than operations-led.

Regional players

• Swipha: Nigerian pharmaceutical manufacturer producing essential medicines for West African markets with WHO PQ-aligned operations. Comparable in regional African pharmaceutical manufacturing focus, though operating in a different African sub-region.

Emerging players

• Strides Pharma Science: Indian pharmaceutical manufacturer with strong Africa-focused generics portfolio and WHO PQ-approved products. Comparable therapeutic and geographic focus, though Strides is a product manufacturer rather than a procurement/services intermediary.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks1 record

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dosch Pharmaceuticals